amfAR Faces Funding Challenges Amid Efforts to Cure HIV/AIDS
amfAR, a leading organization in HIV/AIDS research, is facing significant challenges in its mission to find a cure for the disease. Since its inception in 1985, amfAR has been instrumental in funding scientific research, raising over $950 million and awarding more than 3,900 research grants globally. The organization relies heavily on high-profile fundraising events, such as galas featuring celebrity speakers and auctions, to support its initiatives. However, recent cuts in federal funding for HIV/AIDS research under the Trump administration have increased the demand for amfAR's support, with a 20-fold rise in funding requests from scientists. Additionally, as treatments have improved and public attention has waned, the organization struggles with maintaining awareness and support for its cause.